Molecule Details
| InChIKey | YMEXHIACKAXZLZ-QNOWPQSNSA-N |
|---|---|
| Compound Name | (1S,4S,7R,10S,13S,21R)-21-[[(2R)-2-acetamidohexanoyl]amino]-7-[3-(diaminomethylideneamino)propyl]-10-(1H-indol-3-ylmethyl)-4-(naphthalen-2-ylmethyl)-2,5,8,11,19,22-hexaoxo-3,6,9,12,18,23-hexazatricyclo[21.7.0.024,29]triaconta-24,26,28-triene-13-carboxamide |
| Canonical SMILES | CCCC[C@@H](NC(C)=O)C(=O)N[C@@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2Cc3ccccc3N2C1=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.56 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile